Nureca Ltd closes DRI customs case with ₹57.13 lakh appropriation

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • DRI proceedings against Nureca Ltd closed regarding product classification
  • Pre-deposit of ₹57.13 lakh appropriated as differential duty and interest
  • Liabilities discharged through appropriation, ending the regulatory matter
powered bylight_fuzz_icon
53790111

*this image is generated using AI for illustrative purposes only.

Nureca Limited has received closure of customs proceedings from the Directorate of Revenue Intelligence (DRI) following the appropriation of a pre-deposit amounting to ₹57.13 lakh.

The matter concerned product classification under Section 108 of the Customs Act, 1962. The Commissioner of Customs (NS-V) determined that the initial deposit covered differential duty and applicable interest for imports under relevant Bills of Entry.

Resolution of Regulatory Matter

This development follows an earlier intimation dated May 24, 2026, where Nureca disclosed receipt of a hearing notice from the DRI. The company had subsequently made a pre-deposit of INR 57,12,811 to address the potential liability.

With the recent order, the liabilities arising from the specific imports have been discharged through this appropriation. Consequently, the regulatory matter stands closed without further penalty or extended litigation.

What the Numbers Show

The resolution confirms that the financial impact was limited to the ₹57.13 lakh already provisioned or paid as a pre-deposit. By treating this amount as duty and interest rather than a penalty, the company avoided additional cash outflows beyond the initially estimated liability range.

Historical Stock Returns for Nureca

1 Day5 Days1 Month6 Months1 Year5 Years
+0.36%-3.17%-0.42%+22.65%+35.03%0.0%

Will this resolution influence Nureca's future import compliance protocols or product classification strategies to mitigate similar regulatory risks?

How might the closure of these customs proceedings impact investor sentiment and Nureca's share price volatility in the short term?

Does this outcome set a precedent for other pharmaceutical companies facing similar Section 108 classification disputes with the DRI?

Nureca promoter Saurabh Goyal buys 11,368 shares, stake hits 70.20%

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Saurabh Goyal acquired 11,368 equity shares on September 30, 2026
  • Promoter stake in Nureca Limited rose to 70.20% following the purchase
  • Transaction value stood at ₹4,205,932.64 executed on the NSE
  • Disclosure filed manually due to failure in automated exchange reporting
powered bylight_fuzz_icon
51854790

*this image is generated using AI for illustrative purposes only.

Nureca Limited disclosed manual insider trading filings for Chairman and Managing Director Saurabh Goyal, following a failure in the automated disclosure mechanism on stock exchange platforms. The promoter acquired 11,368 equity shares through open market purchases on September 30, 2026, increasing his stake to 70.20%.

The company stated that transactions undertaken by Goyal on September 30, 2026, did not appear on the exchange platform under the automatic/system-driven disclosure mechanism. Consequently, Nureca submitted these disclosures manually under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as an abundant precaution to ensure records were duly placed on file. This follows earlier disclosures for purchases made between September 10 and September 29, 2026.

Transaction details

The promoter executed purchase transactions across BSE and NSE recently. The latest acquisition involved 11,368 shares valued at ₹4,205,932.64 on the NSE. This transaction increased the shareholding percentage from 70.08% to 70.20%.

Date Exchange Shares Purchased Value (₹) Post-transaction Holding (%)
September 30, 2026 NSE 11,368 4,205,932.64 70.20
September 29, 2026 NSE 3,100 1,118,945.00 70.08
September 28, 2026 NSE 5,618 2,003,884.42 70.05
September 25, 2026 NSE 5,614 1,945,980.82 69.99
September 24, 2026 NSE 2,430 836,503.20 69.93

Prior to this update, the article covered transactions up to September 29, 2026, which raised the stake to 70.08%. The new data supersedes the previous final holding figure.

Regulatory context

Under Regulation 7(2) of the PIT Regulations, designated persons are required to disclose changes in their holdings within two trading days of receipt of such information by the company. However, when transactions are covered under the automated disclosure mechanism, separate manual filings are not ordinarily required. The company noted that since the specific transactions failed to reflect on the exchange platform automatically, manual submission was necessary to maintain compliance and transparency.

The latest disclosure was signed by Nishu Kansal, Company Secretary and Compliance Officer, on October 1, 2026. No derivatives trading was reported by the promoter during this period.

Historical Stock Returns for Nureca

1 Day5 Days1 Month6 Months1 Year5 Years
+0.36%-3.17%-0.42%+22.65%+35.03%0.0%

Will SEBI initiate a review of the automated disclosure infrastructure failures on BSE and NSE to prevent future compliance gaps?

How might the promoter's continued accumulation of shares towards the 75% threshold impact future free float and liquidity for minority shareholders?

Could this manual filing precedent trigger broader regulatory scrutiny or audits regarding insider trading compliance mechanisms across other listed entities?

More News on Nureca

1 Year Returns:+35.03%